Synthovelzen Pharma Private Limited - Company Profile

It is a paper private limited company based in Khairatabad, Telangana, India, established in 2024.
2024 Khairatabad, Telangana, India Active
Last Updated:
Access Report
About Synthovelzen Pharma Private Limited

Synthovelzen Pharma Private Limited, a active private limited company, was established on 01 October 2024 in Khairatabad, Telangana, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000TS2024PTC189860. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.10 M.

Its leadership includes Kirankumar Velaveni (Director), Sai Kiran Reddy Ragi (Director), Ragi Bhuvanesh Reddy (Director). It is based at 8-2-703/2/1 & 8-2-703/2/A,, Aruna Nilayam, Road No.12, Banjara Hills,, Khairatabad, Telangana, 500034.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000TS2024PTC189860

  • Registration Number

    189860

  • Incorporation Date

    01 October 2024

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 5 Months
Company report

Synthovelzen Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Synthovelzen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Synthovelzen Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Kirankumar Velaveni Director 01 Oct 2024 Current
Sai Kiran Reddy Ragi Director 01 Oct 2024 Current
Ragi Bhuvanesh Reddy Director 01 Oct 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Synthovelzen Pharma.

Enhance accessibility to Synthovelzen Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Synthovelzen Pharma revenue growth over time
Synthovelzen Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Synthovelzen Pharma?

Unlock access to Synthovelzen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Synthovelzen Pharma?

Unlock and access historical data on people associated with Synthovelzen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Synthovelzen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Synthovelzen Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Synthovelzen Pharma
Recent Activity within the Organization
  • Director Appointment

    Kirankumar Velaveni was appointed as a Director was appointed as a Director on 01 Oct 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Director Appointment

    Progress on Sai Kiran Reddy Ragi was appointed as a Director was appointed as a Director on 01 Oct 2024 & has been associated with this company since 1 year 5 months . was documented.

  • Director Appointment

    Ragi Bhuvanesh Reddy was appointed as a Director was appointed as a Director on 01 Oct 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Synthovelzen Pharma Private Limited was registered on 01 Oct 2024 with Roc Hyderabad & aged 1 year 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Synthovelzen Pharma Private Limited?

The CIN of Synthovelzen Pharma Private Limited is U21000TS2024PTC189860.

Where is Synthovelzen Pharma Private Limited headquartered?

Synthovelzen Pharma Private Limited is headquartered at 8-2-703/2/1 & 8-2-703/2/A,, Aruna Nilayam, Road No.12, Banjara Hills,, Khairatabad, Telangana, 500034.

When was Synthovelzen Pharma Private Limited incorporated?

Synthovelzen Pharma Private Limited was incorporated on 01 October 2024.

Who are the current directors of Synthovelzen Pharma Private Limited?

The current directors of Synthovelzen Pharma Private Limited are

What is the primary industry of Synthovelzen Pharma Private Limited?

The primary industry of Synthovelzen Pharma Private Limited is Paper.

Is Synthovelzen Pharma Private Limited a listed company?

Synthovelzen Pharma Private Limited is unlisted.

What is the capital structure of Synthovelzen Pharma Private Limited?

The authorized capital of Synthovelzen Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available